News

Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...
Jim Cramer threw a curveball on Pfizer’s stock during a recent caller interaction, suggesting a wait-and-see approach ...
THQ's price and NAV have sharply declined, outpacing its high yield, with no signs of recovery amid sector headwinds. Click ...
Zacks Investment Research on MSN7h
Merck (MRK) Tops Q2 Earnings Estimates
Merck (MRK) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2.28 per share a year ago. These figures are ...
We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Stocks With Huge Catalysts on the Horizon. On May 13, Advanced Micro ...
Pinnacle Associates Ltd. increased its Danaher holdings by 5.3%, now owning shares worth $5.42 million. Institutional ...